Amgen Statistics
NASDAQ: AMGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
413.08+10.48 (+2.60%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Amgen by the numbers
Amgen has a market capitalization of $223.32 billion based on 540.63M shares outstanding. Its trailing P/E ratio is 25.7, below the 4-company peer median of 28.2, and its forward P/E is 16.9. The stock trades 0.6% above its 50-day average and 13.1% above its 200-day average.
Average daily trading volume is 2.72M shares, or about $1.12 billion in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AMGN valuation vs. peer median
| Metric | AMGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $223.32B | $37.94B | +489% |
| P/E (TTM) | 25.7 | 28.2 | -9% |
| Forward P/E | 16.9 | 13.8 | +22% |
| Avg. volume | 2.72M | 1.60M | +71% |
Peer median across 8 companies: GILD, MRNA, ARGX, RVMD, BIIB, BNTX, NBIX, EXEL.
Valuation
- Market cap
- $223.32B
- P/E (TTM)
- 25.66
- Forward P/E
- 16.88
- Price / sales (latest FY)
- 6.08
- EPS (TTM)
- $16.10
- Shares outstanding
- 540.63M
Price and trading
- Previous close
- 402.60
- Open
- 403.06
- Day range
- 401.85 – 415.79
- 52-week range
- 288.00 – 447.03
- 52-week change
- +39.77%
- 50-day moving average
- 410.55
- 200-day moving average
- 365.31
- Beta
- —
- Volume
- 2.22M
- Average volume
- 2.72M
Dividends and events
- Annual dividend
- $9.80
- Dividend yield
- 2.37%
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 223.32B
- Pe
- 25.66
- Forward Pe
- 16.88
- Eps
- 16.10
- Dividend Yield
- 2.50%
- Dividend Rate
- 9.80
- Week52 High
- 447.03
- Week52 Low
- 288.00
- Avg Volume
- 2.72M
- Shares Outstanding
- 540.63M
- Ma50
- 410.55
- Ma200
- 365.31
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -7.59%
- Pct From52w Low
- 43.43%